Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain

purpose of the study To investigate the effect of Kinesio-tape on treatment of nonspecific cardiac chest pain

Study Overview

• Status: Active, not recruiting
• Conditions: Nonspecific Cardiac Chest Pain
• Intervention / Treatment: Other: experimental; Other: traditional

Detailed Description

Nonspecific musculoskeletal chest pain is a major health problem and is a very common and functionally limiting pain complaint. Patients with this problem complain also of significant disability of daily living activities and lost productivity.

The clinical symptom of anterior chest pain generally elicits a long list of diagnoses, when cardiac and pleural conditions are excluded, conditions that affect the musculoskeletal system become important considerations.

The musculoskeletal structures of the thoracic wall and the neck are relatively common sources of chest pain, hypersensitive loci, named myofascial trigger points in the literature, are associated with the Pathophysiology and clinical manifestation of myofascial pain, Rhomboid Muscle trigger point can be a distressing cause of chest pain which can be effectively taken care of by Ischemic compression therapy. Rhomboid muscle trigger points are one of the major causes of nonspecific cardiac chest pain that make the patient seek treatment in different medical health care, but still there is a lake of scientific evidence that supports a particular treatment. Conducting the current study will find an additional solution for this problem.

Kinesio-Taping a technique highly appropriate in patients with soft tissue involvement and plays a major role in the deactivation of trigger points, KT is theorized to have several functions: (1) restoring correct muscle function by supporting weakened muscles, (2) reducing congestion by improving the flow of blood and lymphatic fluid, (3) decreasing pain by stimulating neurological system, (4) correcting misaligned joints by retrieving muscle spasm, and (5) enhancing proprioception through increased stimulation to cutaneous mechanoreceptors

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • Huda Badr Abd Elhamed

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• 30 subjects from both sexes with nonspecific cardiac chest pain 2- Rhomboid trigger point 3-All subjects range from 7 to 9 on VAS. 4-Age range from 20-35. 5- All subjects will complain from limited shoulder ROM

Exclusion Criteria:

• Acute coronary syndrome/ ischemic heart disease 2-Pleurisy 3-Pulmonary lessons like(COPD) Chronic Obstructive Pulmonary Disease,( COAD) Chronic Obstructive Airway Disease and Bronchiectasis, 4-Costochondritis, ' 5-Teitze syndrome, 6-Chest wall syndrome 7-Rheumatologic conditions, 8-Infections in the chest wall 9-Gastro-intestinal problems and 10-Neoplastic disorders

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: experimental; the patient will receive kinsiotape therapy	Other: experimental; 15 patients ˃receive kinisio-tape ,2 session / week for 2 weeks. Followed by stretching exercises, they will be assessed pre and immediately post application, after two weeks and follow up after one month
Active Comparator: traditional; the patient will receive traditional therapy	Other: traditional; 15 patients ˃ will receive ischemic pressure release followed by stretching exercises 2 session / week for 2 weeks, will be assessed pre and immediately post application, after two weeks and follow up after one month.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
PAIN USING VIISUSL ANALOGE SCALE	cm line with 0 (no pain) and 10 (killing pain). The patient places a mark along the line to detect his chest pain level.	up to 2 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
PERSSURE PAIN THRESHOLD	The pressure algometer is a simple handheld pressure algometer, placed perpendicular to the tissue surface and pressure applied steadily at a constant rate	up to 2 weeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
SHOULDER RANGE OF MOTION	digital level inclinometer will used to assess the shoulder ROM .it has an accuracy ± 0.2º for all angles. Measurements were done three times, and an average will be calculated.	up to 2 weeks
shoulder pain and disability	The Shoulder Pain and Disability Index (SPADI) was developed to measure current shoulder pain and disability in an outpatient setting. The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability.	up to 2 weeks

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Actual): March 22, 2024
• Primary Completion (Estimated): June 22, 2024
• Study Completion (Estimated): July 22, 2024

Study Registration Dates

• First Submitted: April 1, 2024
• First Submitted That Met QC Criteria: April 1, 2024
• First Posted (Actual): April 5, 2024

Study Record Updates

• Last Update Posted (Actual): April 5, 2024
• Last Update Submitted That Met QC Criteria: April 1, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Chest Pain
• Other Study ID Numbers: ECM#2024-506

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No